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Bergantin LB, Figueiredo LB, Godinho RO. The lumbrical
muscle: a novel in situ system to evaluate adult skeletal muscle
proteolysis and anticatabolic drugs for therapeutic purposes. J Appl
Physiol 111: 1710–1718, 2011. First published September 15, 2011;
doi:10.1152/japplphysiol.00586.2011.—The molecular regulation of
skeletal muscle proteolysis and the pharmacological screening of
anticatabolic drugs have been addressed by measuring tyrosine release
from prepubertal rat skeletal muscles, which are thin enough to allow
adequate in vitro diffusion of oxygen and substrates. However, the use
of muscle at accelerated prepubertal growth has limited the analysis of
adult muscle proteolysis or that associated with aging and neurode-
generative diseases. Here we established the adult rat lumbrical
muscle (4/hindpaw; 8/rat) as a new in situ experimental model for
dynamic measurement of skeletal muscle proteolysis. By incubating
lumbrical muscles attached to their individual metatarsal bones in
Tyrode solution, we showed that the muscle proteolysis rate of adult
and aged rats (3–4 to 24 mo old) is 45–25% of that in prepubertal
animals (1 mo old), which makes questionable the usual extrapolation
of proteolysis from prepubertal to adult/senile muscles. While acute
mechanical injury or 1- to 7-day denervation increased tyrosine
release from adult lumbrical muscle by up to 60%, it was reduced by
20–28% after 2-h incubation with -adrenoceptor agonists, forskolin
or phosphodiesterase inhibitor IBMX. Using inhibitors of 26S-pro-
teasome (MG132), lysosome (methylamine), or calpain (E64/leupep-
tin) systems, we showed that ubiquitin-proteasome is accountable for
40–50% of total lumbrical proteolysis of adult, middle-aged, and aged
rats. In conclusion, the lumbrical model allows the analysis of muscle
proteolysis rate from prepubertal to senile rats. By permitting eight
simultaneous matched measurements per rat, the new model improves
similar protocols performed in paired extensor digitorum longus
(EDL) muscles from prepubertal rats, optimizing the pharmacological
screening of drugs for anticatabolic purposes.
protein degradation; tyrosine release; muscle atrophy; ubiquitin-pro-
teasome; calpain
IN VERTEBRATES, skeletal muscle functions as an important
regulator of body energy homeostasis, providing amino acids
generated from protein breakdown (5, 30, 54). However, in-
creased protein breakdown is the major determinant of muscle
atrophy associated with pathological conditions, such as dia-
betes, cancer cachexia, or neuromuscular dysfunction (25, 29,
30). By studying the molecular mechanisms underlying the
loss of muscle mass it is possible to define new targets for
development of therapeutic interventions to counteract or re-
verse muscle atrophy.
In general, these mechanisms as well as the pharmacological
screening of drugs that interfere with muscle atrophy have been
addressed by measuring the ex vivo release of tyrosine from
muscles (4, 26, 32, 50, 55), an amino acid that is neither
synthesized nor metabolized by this tissue (3, 17).
Tyrosine can be easily measured by colorimetric or fluoro-
metric assay (52). However, because incubation procedures
demand intact muscles sufficiently thin to allow an adequate
diffusion of nutrients and oxygen (3), until now almost all
muscle proteolysis studies have been performed in skeletal
muscle from sexually immature (30–40 day old) rats (4, 14,
19, 26, 32, 50). At prepubertal age, skeletal muscle exhibits
important metabolic characteristics that differ from those of
adulthood, such as accelerated growth (10), increased insulin-
stimulated glucose uptake (42), and reduced levels of anabolic
sexual hormones (45). Therefore, it is not accurate to expand
the conclusions obtained with prepubertal rat muscle to adult-
hood. In addition, the effect of aging or neurodegenerative
diseases on muscle protein breakdown cannot be assessed
directly in this model, requiring the use of cultured myotube
models (53) or the alternative analysis of muscle static mark-
ers, such as MAFbx/Atrogin-1 and MuRF1 (6, 22, 40). How-
ever, recent findings concerning MAFbx/Atrogin-1 have
shown unexpected problems of interpretation, since MAFbx/
Atrogin-1 might also influence protein synthesis (2, 33).
To overcome the limitation of measuring protein breakdown
rate in skeletal muscles from sexually immature rats, we
evaluated whether lumbrical muscles from adult rats would
satisfy the requirements for proteolysis experiments. In addi-
tion, taking into account the presence of four small lumbrical
muscles in each hindpaw (8 muscles/rat), the use of lumbrical
muscle as a proteolysis experimental model would allow the
simultaneous analysis of eight matched samples compared with
the current protocol that uses paired extensor digitorum longus
(EDL) muscles from prepubertal rats.
MATERIALS AND METHODS
Animals. Experiments were performed in lumbrical and EDL muscles
isolated from prepubertal (1 mo old), adult (3–4 mo old), middle-aged
(12 mo old), and aged (24 mo old) Wistar rats from the institutional
animal care facility. Rats were maintained on a 12:12-h light-dark cycle
with free access to water and standard lab diet. All procedures were in
accordance with the Guide for the Care and Use of Laboratory Animals
prepared by the National Academy of Sciences and published by the
National Institutes of Health and were approved by the Institutional
Ethics Committee (protocols no. 1123/07 and no. 1431/08).
Muscle morphological studies. Animals were killed by decapita-
tion, and lumbrical and EDL muscles from both hindlimbs were
removed, weighed, dehydrated in starch, and embedded in Tissue-Tek
OCT compound (Miles Laboratories, Naperville, IL). After fixing in
corks, muscles were immediately frozen in liquid nitrogen and stored
at80°C. To determine muscle fiber diameter, cryostat cross sections
(5 m) of the lumbrical and EDL muscles were stained with hema-
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toxylin and eosin (H & E), as described by Fukushima et al. (16).
Images of stained myofibers (7 fields/section) were acquired under
light microscope (Nikon Eclipse E800, Melville, NY;40 objective),
analyzed with HL Image 97 software (Western Vision Software,
Layton, UT), and processed with Adobe Photoshop CS 4.0 (Adobe
Systems, Mountain View, CA). Frequency histograms of lumbrical
fiber diameter from adult male rats were constructed and compared
with those obtained from EDL muscles.
Muscle proteolysis analysis. Rats were killed by decapitation, and
lumbrical (8/rat) and EDL (2/rat) muscles were removed and carefully
dissected. To avoid tissue damage, lumbrical muscles were kept
attached by tendons to their own metatarsal bones at exact resting
length, while EDL muscles were pinned by their tendons on inert
plastic supports at approximately resting length. Each lumbrical/bone
or EDL system was transferred to 1.5-ml tubes containing carbogen-
saturated Tyrode solution (in mM: 135 NaCl, 5 KCl, 1 MgCl2, 15
NaHCO3, 2 NaH2PO4, 2 CaCl2, 11 glucose, pH 7.4, at 37°C) plus 0.5
mM cycloheximide (Tyrode-C) to prevent protein synthesis and
reincorporation of tyrosine back into proteins. After a 30-min equil-
ibration period, tissues were transferred to microtubes and incubated
with drugs, in a 1.5-ml final volume of fresh Tyrode-C, in a humid-
ified atmosphere of 95% air and 5% CO2 at 37°C. After 1–5 h, 500-l
aliquots were collected and immediately used for proteolysis deter-
mination. The muscles were disconnected from the metatarsal bones,
carefully dissected to remove tendons, and subsequently weighed.
Experimental design. To validate the lumbrical muscle as a model
to evaluate skeletal muscle proteolysis of adult rat, we conducted
several experiments including measurement of basal tyrosine release
from control, denervated, or acutely injured lumbrical muscles from
3- to 4-mo-old rats.
The contribution of ubiquitin-proteasome, calpain, and lysosomal
systems to muscle proteolysis was evaluated in lumbrical muscles
from 4-mo-old rats in the presence of 20 M MG132 (26S-protea-
some inhibitor) (26, 50), 10 mM methylamine (lysosome inhibitor)
(19, 38), or 25 M E64 plus 50 M leupeptin (calpain inhibitors) (39,
55). Age-dependent changes in the total and proteasome-dependent
proteolysis were followed in lumbrical muscle from 1-, 4-, 12-, and
24-mo-old rats. In addition, the involvement of the 2-adrenergic/
cAMP signaling pathway in the regulation of muscle proteolysis was
assessed in muscles from adult rats incubated with 10–100 M
isoproterenol (nonselective -adrenoceptor agonist), 1–10 nM formot-
erol (2-adrenoceptor agonist), 100–1,000 M IBMX (nonselective
phosphodiesterase inhibitor), and 10–100 nM forskolin (adenylyl
cyclase activator). Finally, results obtained with 3 nM formoterol and
100 nM forskolin in lumbrical muscle of adult rats were compared
with those obtained in EDL and lumbrical muscles of prepubertal rats.
Fluorometric determination of tyrosine release. Muscle proteolysis
was determined by measuring the rate of tyrosine release into the
incubation medium. The method initially developed by Waalkes and
Udenfriend in 1957 (52) has been adapted to the 96-well microplate as
described here in detail. Samples (500 l) were incubated for 30 min
at 55°C with 200 l of a 1:1 (vol/vol) reaction mixture: 1% (wt/vol)
1-nitroso-2-naphthol diluted in ethanol and 72.5 mM sodium nitrite in
20% nitric acid. After cooling for 10 min, extraction of unreacted
Fig. 1. Lumbrical muscles of adult rat. A: right paw
of a 4-mo-old male rat showing the 4 lumbrical
muscles, numbered from 1 (medial) to 4 (lateral)
according to anatomic position. B–F: cross sections
(5 m) of 4 lumbrical (B–E) and extensor digitorum
longus (EDL; F) muscles stained with hematoxylin
and eosin (H & E). Bar, 20 m.
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1-nitroso-2-naphthol was performed by adding 1 ml of 1,2-dichloro-
ethane. This extraction procedure increased by 200 times the sensi-
tivity of tyrosine measurement previously proposed by Lutke-Eversloh and
Stephanopoulos (35). The samples were then vigorously mixed and
centrifuged for 10 min at 800 g, and tyrosine was quantified from the
upper aqueous phase by fluorometric assay in 96-well microplates
with excitation/emission wavelengths of 485 nm/590 nm. Rates of
proteolysis were expressed as nanomoles of tyrosine per milligram of
wet mass per hour.
To measure total muscle tyrosine content, lumbrical muscles were
homogenized with 10 vol of 5% perchloric acid (PCA) and centri-
fuged at 10,000 g for 10 min (29). Total muscle protein content was
measured by Bradford protein assay. The fractional degradation rate
(FDR) of total protein was calculated as follows:
FDR
rate of tyrosine nmol/h g 24h
total tyrosine content
g muscle protein
Mechanical injury and denervation of lumbrical muscles. To in-
vestigate whether the novel model could detect changes in tyrosine
release induced by acute mechanical injury, concentric cuts in the
medial region of lumbrical muscles were performed immediately
before the proteolysis analysis with rat-tooth forceps.
Denervation of hindlimb muscles from adult rats was carried out
under ketamine (48 mg/kg) and xylazine (6 mg/kg) anesthesia by
cutting the tibial nerve. To prevent muscle reinnervation, a 2- to 3-mm
distal segment of nerve end was removed. After 1–7 days, at the time
of the experimental procedure, lumbrical and EDL muscle denerva-
tion was confirmed by the absence of contraction in response to
repetitive stimulation of the nerve stump.
Statistical analysis. Results are expressed as means  SE or 
95% confidence limits (CLs). Differences in muscle mass (from EDL
of prepubertal vs. adult rats or from injured vs. control lumbrical
muscles of adult rats) or tyrosine release rate (from injured vs. control
lumbrical muscles) were analyzed by two-tailed unpaired Student’s
t-test. Nonparametric Kruskal-Wallis followed by Dunn’s multiple
comparison tests were used to evaluate the statistical significance of
EDL and/or lumbrical fiber diameter results. The effects of 1) fors-
kolin and formoterol, 2) leupeptin/E64 and MG132  leupeptin/E64,
and 3) methylamine and MG132  methylamine on muscle proteol-
ysis were compared with one-way ANOVA followed by Tukey’s
multiple comparison test. One-way ANOVA followed by Newman-
Keuls multiple comparison tests were used to test the effect of aging
or of multiple concentrations of isoproterenol, forskolin, formoterol,
or IBMX on muscle proteolysis. The level of significance was set at
5% (P 0.05), and all analyses were performed with GraphPad Prism
for Windows 5.01.
RESULTS
Morphometric analysis of lumbrical muscles. Figure 1
shows lumbrical muscles from adult rat, numbered 1–4 ac-
cording to their anatomic position (Fig. 1A), and representative
images of H & E-stained lumbrical (Fig. 1, B–E) and EDL
(Fig. 1F) muscles.
Morphometric analysis of muscle cross sections (Fig. 1,
B–E) did not detect any statistically significant difference
between fiber diameter of lumbrical muscles 1, 2, and 4 [26.39
m (CL  25.92–26.87) to 27.18 m (CL  26.69–27.67);
n 432–464], which represented 95–98% of lumbrical muscle
3 (Fig. 2C; n  402). However, the EDL fiber diameter [34.69
m (CL  33.86–35.51); n  344; Fig. 2, B and C] was
25–31% higher than those of lumbrical muscles (Fig. 2, C
and D).
Fig. 2. Mass and fiber diameter of lumbrical
and EDL muscles from prepubertal and adult
rats. A and C: wet mass (n  4–8 muscles; A)
and fiber diameter (C) of lumbrical (numbered
according to anatomic position; n  402–464
muscle fibers) and EDL muscles from adult or
prepubertal rats (n 344 muscle fibers). B and
D: frequency distribution of EDL (B) and
lumbrical (D) fiber diameters. Each bar repre-
sents mean  SE (A) or confidence limits (B)
of values obtained from 4–8 rats. aSignifi-
cantly different from EDL of adult rat; bsig-
nificantly different from EDL of prepubertal
rat (P  0.05; A, ANOVA followed by
Tukey’s multiple comparison test; C, Kruskal-
Wallis followed by Dunn’s multiple compari-
son test).
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There was no statistical difference in mass values among the
four adult lumbrical muscles (38.6  0.6 to 39.5  0.7 mg;
n  4). While lumbrical muscle mass from adult rats was
one-third of the EDL value (124.3  0.3 mg; n  4), it was
approximately equal to EDL mass from 1-mo-old rats (30.9 
0.7 mg; n  16; Fig. 2A).
Basal tyrosine release from lumbrical muscles and its rela-
tionship with muscle anatomic position. To evaluate the rate of
muscle proteolysis, lumbrical muscles from adult rats were
incubated for 1–5 h in Tyrode-C at 37°C. As shown in Fig. 3A,
the basal release of tyrosine from lumbrical muscle into the
medium increased linearly from 0.125  0.04 to 0.42  0.03
nmol/mg muscle (n  6–9), reaching a plateau after 3 h.
Considering the total amount of tyrosine (482.2  10.4 nmol/g
protein) and the basal rate of tyrosine release (1.25 nmol
tyrosine·g protein1·h1), the daily basal FDR of adult rat
lumbrical muscle was 6.21  0.14%.
It is important to note that no significant difference in
tyrosine release rate was detected among the four lumbrical
muscles, indicating that basal proteolysis is equivalent in the
four muscles. Furthermore, the release of tyrosine from meta-
tarsal bone alone was negligible (Fig. 3B), indicating that
skeletal muscle is the main source of tyrosine detected in the
medium. On the basis of these data, in subsequent experiments
determination of tyrosine release was performed after 2-h
incubation with individual lumbrical muscle/metatarsal bone
(n  8 muscles/rat).
Effect of mechanical injury and denervation in lumbrical
muscle proteolysis. To assess whether the lumbrical model
could be used to detect changes in protein breakdown induced
by wound or disuse, we evaluated the effect of mechanical
injury or surgical denervation of lumbrical muscles on the
release of tyrosine. As shown in Fig. 4A, acute injury increased
by 60% the basal lumbrical proteolysis rate (0.14  0.01
nmol·mg1·h1), which in the prepubertal muscle model has
been associated with intense influx of Ca2 and subsequent
increase of Ca2-dependent protein breakdown (19).
Likewise, denervation of lumbrical muscle for 3 and 7 days
increased by 28% and 64% the basal protein breakdown rate
(0.14  0.01 nmol·mg1·h1; Fig. 4B), which was accompa-
nied by 10% and 25% reduction of muscle mass (control 
38.5  1.2 mg; Fig. 4C), validating the adult rat lumbrical
muscle as a model to study skeletal muscle proteolysis.
Fig. 4. Effect of acute mechanical injury (A) or 1- to 7-day denervation (B and
C) of lumbrical muscles on wet mass (A, C) and on rate of proteolysis (A and
B). Each bar represents mean  SE of values obtained from 3–4 adult male
rats. aSignificantly different from control group; bsignificantly different from
1-day denervated group; csignificantly different from control 3-day denervated
group (P  0.05; A, Student’s t-test; B and C, ANOVA followed by Newman-
Keuls multiple comparison test).
Fig. 3. Tyrosine release from adult rat lumbrical muscles. A: muscles of
4-mo-old male rats were incubated in Tyrode solution with cycloheximide
(Tyrode-C) for 1–5 h. B: lumbrical muscles, numbered according to their
anatomic position, and metatarsal bones were incubated in Tyrode-C for 2 h.
Tyrosine released into the medium was measured by fluorometric assay. Each
bar represents mean  SE of 3–9 muscles from 3–5 rats. ND, not detected.
1713RAT LUMBRICAL MUSCLE MODEL FOR PROTEOLYSIS STUDY
J Appl Physiol • VOL 111 • DECEMBER 2011 • www.jap.org
Contribution of ubiquitin-proteasome, calpain, and lyso-
somal systems to lumbrical muscle proteolysis. The major
pathways of skeletal muscle protein degradation involve ATP-
dependent ubiquitin-proteasome and Ca2-dependent calpain
systems (25). To assess the contribution of these pathways to
the basal proteolysis of lumbrical muscles from adult rats,
tyrosine release was evaluated in muscles preincubated with 20
M MG132, an inhibitor of the ubiquitin-proteasome system
(26, 50), 25 M E64 plus 50 M leupeptin to inhibit the
calpain system (19, 38, 39), or 0.2% DMSO as vehicle. MG132
and E64/leupeptin reduced by 39% and 25% the proteolysis
obtained in the presence of DMSO (0.12  0.01
nmol·mg1·h1, Fig. 5A). To examine the role of lysosome in
the degradation of lumbrical muscle proteins, we measured the
release of tyrosine in the presence of 10 mM methylamine. The
lysosomal inhibitor reduced the basal rate of tyrosine release
by 17% (Fig. 5B). Combination of MG132 with E64/leupeptin
(Fig. 5A) or with methylamine (Fig. 5B) had no additive effect,
which confirms the current theory that the ubiquitin-
proteasome pathway is the rate-limiting step in the proteolytic
process of skeletal muscle catabolism (25). Incubation of
muscles with DMSO alone did not modify the basal release of
tyrosine (data not shown).
Effect of modulators of cAMP signaling pathway in skeletal
muscle proteolysis. Considering the crucial role of stimulatory
G (Gs) protein/adenylyl cyclase (AC)/cAMP in the mainte-
nance of muscle mass (31), established exclusively in the
prepubertal skeletal muscle model (4, 26, 32), we analyzed the
effect of activators of -adrenoceptor/cAMP signaling on lum-
brical muscles from adult rats. The nonselective -adrenocep-
tor agonist isoproterenol (30–100 M) decreased by 14–20%
basal tyrosine release (0.16  0.01 nmol·mg1·h1; Fig. 6A).
Isoproterenol’s effect was mimicked by the selective 2-adre-
noceptor agonist formoterol (3–10 nM), which reduced by
Fig. 5. Contribution of ubiquitin-proteasome and calpain systems on lumbrical
muscle proteolysis. The rate of lumbrical muscle proteolysis was measured in
the presence or absence of proteasome inhibitor MG132 (20 M) and calpain
inhibitors E-64/leupeptin (Leup) (25 M/50 M) (A) or lysosomal inhibitor
methylamine (Methyl, 10 mM) (B). After 2 h, tyrosine released into the
medium was measured by fluorometric assay. Each bar represents mean  SE
of values obtained from 8 muscles of 4 adult male rats. aSignificantly different
from control group (P  0.05; ANOVA followed by Tukey’s multiple
comparison test).
Fig. 6. Inhibitory effect of the receptor-activated
Gs protein (GsPCR)/cAMP signaling system on
lumbrical muscle proteolysis. The rate of lum-
brical muscle proteolysis was measured in the
presence or absence of -adrenoceptor agonists
isoproterenol (10–100 M; A) and formoterol
(1–10 nM; B), phosphodiesterase inhibitor
IBMX (100–1,000 M; C), and adenylyl cy-
clase activator forskolin (10–100 nM; D). After
2 h, tyrosine released into the medium was
measured by fluorometric assay. Each bar rep-
resents mean  SE of values obtained from
4–16 muscles of 3–6 adult male rats. aSignifi-
cantly different from control group (P  0.05;
ANOVA followed by Newman-Keuls multiple
comparison test).
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22–27% basal proteolysis (0.16  0.01 nmol·mg1·h1; Fig.
6B). Furthermore, incubation of lumbrical muscle with the
nonselective phosphodiesterase inhibitor IBMX (0.1–1.0 mM)
reduced by up to 20% the basal proteolysis (0.14  0.01
nmol·mg1·h1; Fig. 6C). Finally, direct activation of AC with
100 nM forskolin reduced by 20% the basal tyrosine release
from muscle (0.15  0.01 nmol·mg1·h1; Fig. 6D). By
showing the inhibitory effect of the AC/cAMP cascade on
protein breakdown of adult skeletal muscle, our results support
the idea that AC/phosphodiesterases are potential pharmaco-
logical targets for anticatabolic therapy, previously demon-
strated in muscles from prepubertal rats (37).
Age-dependent changes in lumbrical muscle proteolysis. To
assess whether the lumbrical experimental model allows direct
analysis of age-related changes in proteolysis muscle, we
compared the rate of proteolysis of lumbrical muscles from
prepubertal (1 mo old), adult (4 mo old), middle-aged (12 mo
old), and senile (24 mo old) rats. As shown in Fig. 7A, total
muscle proteolysis was maximal in the prepubertal rat (0.31 
0.010 nmol·mg1·h1), being reduced by 55% in adult (0.14 
0.005 nmol·mg1·h1) and by 71–74% in middle-aged (0.08 
0.004 nmol·mg1·h1) and aged (0.09  0.008 nmol·mg1·h1)
rats. From prepuberty to adulthood, changes in protein break-
down were inversely proportional to the gain of muscle mass
(prepubertal  22.2  0.8 mg, adult  37.1  0.7 mg; Fig.
7B). In contrast, lumbrical muscle from aged rats atrophied
(25.9  0.9 mg), reaching mass values close to those of
prepubertal rats. The sarcopenia detected in 24-mo-old rats was
accompanied by 16% loss of body mass compared with the
4-mo-old group (Fig. 7C).
To investigate whether the magnitude of decrease in muscle
proteolysis was correlated to age-dependent changes in protea-
some activity, we determined the tyrosine release from lum-
brical muscles in the absence or presence of 20 M MG132.
As shown in Fig. 7A, MG132 reduced proteolysis in muscle by
40–50% from prepubertal to aged rats, validating the use of the
lumbrical model to analyze age-dependent changes in the rate
of muscle protein breakdown.
Comparison between lumbrical muscle model system and
current methodology. Finally, the efficiency of the new ex vivo
model proposed here was compared with the current method-
ology, which uses EDL muscles from prepubertal rats. By
analyzing the effect of forskolin and formoterol, our results
showed that either direct or receptor-dependent activation of
AC reduced by 	20% the proteolysis of lumbrical (0.32 
0.01 nmol·mg1·h1) and EDL (0.10  0.01 nmol·mg1·h1)
muscles from prepubertal rats (Fig. 8, A and B). More impor-
tant, by using lumbrical muscle we were able to show that
activation of AC also reduces proteolysis in muscles of adult
rats (Fig. 8C). On the other hand, the evaluation of muscle
proteolysis could not be performed in EDL muscles from adult
rats because of methodological limitations related to muscle
thickness.
DISCUSSION
In the present study, we established and validated the rat
lumbrical muscle as a new ex vivo experimental model for the
dynamic measurement of skeletal muscle proteolysis in prepu-
bertal, adult, and/or aged rats. All four adult rat lumbrical
muscles have similar tyrosine release rate (Fig. 3B) with a daily
basal FDR of 6.21  0.14%, which is not different from that
obtained in vivo in perfused adult rat hindquarters (6.8 
0.12%) (29).
Adult rat lumbrical muscles have contraction properties
similar to those of EDL muscles (20), but their major advan-
tage is that they are thin enough to allow a suitable measure-
ment of tyrosine release (Fig. 2), which is not possible with
EDL muscles because of the inevitable necrosis of inner
muscle fibers (3). Moreover, taking into account the similar
rate of tyrosine release of all four lumbrical muscles (Fig. 3B),
this model has a numerical advantage (8 muscles/rat) over the
established experimental model, paired EDL muscles. By using
eight lumbrical muscles per animal, it is possible to compare
seven matched experimental groups with a control value ob-
Fig. 7. Age-related changes in lumbrical muscle proteolysis. A: rate of
proteolysis was measured in lumbrical muscle from 1-, 4-, 12-, and 24-mo-old
male rats. Lumbrical muscles were incubated in Tyrode-C for 2 h in the
presence or absence of proteasome inhibitor MG132 (20 M). Tyrosine
released into the medium was measured by fluorometric assay. B: muscle mass.
C: body mass. Each bar represents mean SE of 6–16 muscles from 3–4 rats.
aSignificantly different from 1-mo group; bsignificantly different from 4-mo
group; csignificantly different from 12-mo group (P 0.05; ANOVA followed
by Newman-Keuls multiple comparison test).
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tained in the same animal (e.g., 1 control vs. 7 different drugs
or vs. 7 different concentrations of a drug). In contrast, it would
be necessary to use at least 8 EDL muscle (4 rats) to perform
unpaired analysis or 14 EDL (7 rats) to perform paired analysis
(one muscle as control and the contralateral one as experimen-
tal muscle). Thus the use of the lumbrical model might sub-
stantially reduce the number of animals assigned to ex vivo
proteolysis experiments. In addition, here we adapted for the
96-well microplate the fluorometric macromethod for tyrosine
measurement described by Waalkes and Udenfriend (52),
which reduced by 	90% the amount of chemical waste pro-
duced.
Furthermore, the lumbrical model here presented was able to
detect changes in tyrosine release induced by either acute
mechanical injury or muscle denervation (Fig. 4), which in-
volve Ca2-dependent calpain (19) and ATP-dependent pro-
teasome (25) mechanisms, validating the use of adult rat
lumbrical muscle for evaluation of the major proteolytic sys-
tems responsible for skeletal muscle protein breakdown.
In fact, the relative contribution of ATP, Ca2-dependent,
and lysosomal proteolytic systems to adult skeletal muscle
proteolysis was assessed by incubation of lumbrical muscles
with inhibitors of proteasome (MG132) (27), calpain (leupep-
tin and E64) (55), and lysosome (methylamine) systems. Our
results clearly showed that the proteasome system is the major
route of protein degradation in adult skeletal muscle (Fig. 5).
Interestingly, association of MG132 with calpain (Fig. 5A) or
lysosome (Fig. 5B) inhibitors had no additive effect, which
supports the current theory that the ubiquitin-proteasome path-
way is the limiting step of skeletal muscle proteolysis (43).
The lumbrical model also allows a strict quantitative analy-
sis of signal transduction pathways involved in the regulation
of muscle proteolysis. It is well accepted that the cAMP
signaling pathway mediates the biological action of many
endogenous substances or synthetic drugs (e.g., catecholamines and
2-adrenoceptor agonists) via receptor-activated Gs proteins
(GsPCR) (1, 7, 15, 18, 21, 23, 46, 51).
The anticatabolic effect of 2-adrenoceptor agonists in-
volves distinct cAMP-dependent pathways, such as those as-
sociated with activation of PKA, which increases expression
and activation of calpastatin, an endogenous regulator of m-
calpain (9, 48). Many in vivo and ex vivo studies have
confirmed the therapeutic potential of 2-adrenoceptor agonists
for attenuating or reversing muscle wasting (for review, see
Ref. 36). Some of these have been based on ex vivo proteolysis
experiments performed with prepubertal rat muscles (12, 26,
28, 32, 37, 47, 50). Here we found that -adrenergic agonists
isoproterenol (nonselective) and formoterol (2-selective) also
reduced proteolysis of adult rat skeletal muscle by 12–20%.
Similar effects were obtained by using drugs that increase
intracellular cAMP levels, via activation of AC (forskolin) or
inhibition of phosphodiesterases (IBMX). These observations
highlight the GsPCR/AC/cAMP system as a pharmacological
target for anticatabolic therapies and attenuation of adulthood
and age-dependent skeletal muscle protein breakdown.
More importantly, by comparing the tyrosine release from
lumbrical muscle of prepubertal, adult, and aged rats, we
showed that overall skeletal muscle proteolysis decreases with
maturation and aging (Fig. 7A). This observation alone makes
questionable the direct extrapolation of results obtained from
prepubertal muscles to adult or senile muscles. In fact, Reyn-
olds et al. in 2002 made similar observations with 2- to
4-mo-old to 12- to 17-mo-old male B6C3F1 mice, showing
that skeletal muscle proteolysis is lower with maturity (44). In
addition, the decline in total and proteasome-dependent muscle
proteolysis observed during aging (Fig. 7A) is supported by
previous studies showing a marked reduction of Atrogin-1/
MAFbx and MuRF1 levels (13) and of chymotrypsin and
trypsin-like activities of proteasome in senescent muscles (8,
Fig. 8. Effect of modulators of 2-adrenoceptor/
cAMP signaling pathway on proteolysis of lumbri-
cal muscles (A and C) and EDL (B) from prepu-
bertal and adult male rats. The rate of proteolysis of
lumbrical muscle from 1 (A)- and 4 (C)-mo-old rats
was measured in the presence or absence of 2-
adrenoceptor agonist formoterol (Form, 3 nM) and
adenylyl cyclase activator forskolin (Forsk, 100
nM) and compared with those of EDL from prepu-
bertal rats. Because of methodological limitations,
it was not possible to evaluate the rate of proteol-
ysis of EDL muscles from adult rats. Each bar
represents mean  SE of values obtained from
4–16 muscles of 3–6 adult male rats. aSignificantly
different from control group (P  0.05; ANOVA
followed by Newman-Keuls multiple comparison
test).
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24, 41), which might contribute to accumulation of damage
proteins in skeletal muscle during senescence (34).
Finally, a high rate of protein synthesis is observed in
skeletal muscles of newborn rats, but as maturation progresses
this rate declines rapidly (11). As consequence, in adult life,
the basal fractional synthesis rate (FSR) of rat fast-twitch
muscles reaches values similar to those of the basal FDR
(6.8%/day) (29, 49), which is quite similar to lumbrical FDR
values (6.2%/day) obtained in the present study. Altogether,
these data indicate an appropriate balance between basal pro-
tein synthesis and degradation in adult lumbrical skeletal mus-
cle.
In summary, we have established an in situ experimental
model—the lumbrical muscle—for dynamic measurement of
proteolysis in skeletal muscles from prepubertal to aged rats,
which overcomes the methodological limitation of using only
sexually immature rats. This is of special relevance considering
that muscle proteolysis in the adult rat is 	50% of that in the
1-mo-old animal, which limits the direct extrapolation of
results obtained from prepubertal muscles to adult or senile
muscles. Finally, the use of eight lumbrical muscles per rat and
the adjustment of the tyrosine assay to a 96-well microplate
format definitively may reduce the number of animals and
chemical waste in the experimental analysis of skeletal muscle
proteolysis, optimizing the pharmacological screening of anti-
catabolic drugs for treatment and prevention of specific adult-
onset diseases or those associated with aging.
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